^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    THBS2-L

    i
    Other names: THBS2, Thrombospondin 2, TSP2
    Entrez ID:
    7058
    7ms
    Systematic analysis of integrated bioinformatics to identify upregulated THBS2 expression in colorectal cancer cells inhibiting tumour immunity through the HIF1A/Lactic Acid/GPR132 pathway. (PubMed, Cancer Cell Int)
    THBS2 expression is associated with PFI, immune cell infiltration, immune regulation, cell death, cell migration, epithelial-mesenchymal transition, angiogenesis and genomic variations in COAD. THBS2 may serve as a biomarker for immunotherapy in COAD. Upregulated THBS2 expression in CRC cells inhibits anti-tumour immunity through the HIF1A/lactic acid/GPR132 pathway.
    Journal • IO biomarker
    |
    HIF1A (Hypoxia inducible factor 1, alpha subunit) • THBS2 (Thrombospondin 2)
    |
    HIF1A expression • THBS2-L
    over1year
    Thrombospondin-2 as a Predictive Biomarker for Hepatocellular Carcinoma after Hepatitis C Virus Elimination by Direct-Acting Antiviral. (PubMed, Cancers (Basel))
    Serum TSP-2 levels are a predictive biomarker of HCC occurrence in CHC patients after HCV elimination by DAA treatment. The AFT score using TSP-2, AFP, and the FIB-4 index may identify those who require HCC surveillance.
    Journal
    |
    AFP (Alpha-fetoprotein) • THBS2 (Thrombospondin 2)
    |
    THBS2-L